This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Autologous hematopoietic stem cell transplantation promotes connective tissue remodeling in systemic sclerosis patients
Arthritis Research & Therapy Open Access 29 April 2022
-
Long-term immune reconstitution and T cell repertoire analysis after autologous hematopoietic stem cell transplantation in systemic sclerosis patients
Journal of Hematology & Oncology Open Access 19 January 2017
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Katsumoto TR, Whitfield ML, Connolly MK . The pathogenesis of systemic sclerosis. Annu Rev Pathol 2011; 6: 509–537.
Baraut J, Michel L, Verrecchia F, Farge D . Relationship between cytokine profiles and clinical outcomes in patients with systemic sclerosis. Autoimmun Rev 2010; 10: 65–73.
Hasegawa M, Fujimoto M, Matsushita T, Hamaguchi Y, Takehara K, Sato S . Serum chemokine and cytokine levels as indicators of disease activity in patients with systemic sclerosis. Clin Rheumatol 2011; 30: 231–237.
Giacomelli R, Cipriani P, Danese C, Pizzuto F, Lattanzio R, Parzanese I et al. Peripheral blood mononuclear cells of patients with systemic sclerosis produce increased amounts of interleukin 6, but not transforming growth factor beta 1. J Rheumatol 1996; 23: 291–296.
Iversen L, Østergaard O, Ullman S, Nielsen C, Halberg P, Karlsmark T et al. Circulating microparticles and plasma levels of soluble E- and P-selectins in patients with systemic sclerosis. Scand J Rheumatol 2013; 42: 473–482.
Distler JHW, Strapatsas T, Huscher D, Dees C, Akhmetshina A, Kiener HP et al. Dysbalance of angiogenic and angiostatic mediators in patients with mixed connective tissue disease. Ann Rheum Dis 2011; 70: 1197–1202.
Burt RK, Shah SJ, Dill K, Grant T, Gheorghiade M, Schroeder J et al. Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial. Lancet 2011; 378: 498–506.
van Laar JM, Farge D, Sont JK, Naraghi K, Marjanovic Z, Larghero J et al. Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis. JAMA 2014; 311: 2490–2498.
Farge D, Henegar C, Carmagnat M, Daneshpouy M, Marjanovic Z, Rabian C et al. Analysis of immune reconstitution after autologous bone marrow transplantation in systemic sclerosis. Arthritis Rheum 2005; 52: 1555–1563.
Baraut J, Grigore EI, Jean-Louis F, Khelifa SH, Durand C, Verrecchia F et al. Peripheral blood regulatory T cells in patients with diffuse systemic sclerosis (SSc) before and after autologous hematopoietic SCT: a pilot study. Bone Marrow Transplant 2014; 49: 349–354.
Tsukamoto H, Nagafuji K, Horiuchi T, Mitoma H, Niiro H, Arinobu Y et al. Analysis of immune reconstitution after autologous CD34+ stem/progenitor cell transplantation for systemic sclerosis: predominant reconstitution of Th1 CD4+ T cells. Rheumatology (Oxford) 2011; 50: 944–952.
Vonk MC, Marjanovic Z, van den Hoogen FHJ, Zohar S, Schattenberg AVMB, Fibbe WE et al. Long-term follow-up results after autologous haematopoietic stem cell transplantation for severe systemic sclerosis. Ann Rheum Dis 2008; 67: 98–104.
Gourh P, Arnett FC, Assassi S, Tan FK, Huang M, Diekman L et al. Plasma cytokine profiles in systemic sclerosis: associations with autoantibody subsets and clinical manifestations. Arthritis Res Ther 2009; 11: R147.
Alecu M, Geleriu L, Coman G, Gălăţescu L . The interleukin-1, interleukin-2, interleukin-6 and tumour necrosis factor alpha serological levels in localised and systemic sclerosis. Rom J Intern Med 1998; 36: 251–259.
Distler O, Distler JHW, Scheid A, Acker T, Hirth A, Rethage J et al. Uncontrolled expression of vascular endothelial growth factor and its receptors leads to insufficient skin angiogenesis in patients with systemic sclerosis. Circ Res 2004; 95: 109–116.
van Bon L, Affandi AJ, Broen J, Christmann RB, Marijnissen RJ, Stawski L et al. Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis. N Engl J Med 2014; 370: 433–443.
Acknowledgements
This work was supported by Groupe Francophone de Recherche sur la Sclérodermie (GFRS), Association des Sclérodermiques de France (ASF), INSERM, Agence Nationale pour la Recherche, the Délégation Régionale à la Recherche Clinique (DRRC) from the Assistance Publique-Hôpitaux de Paris (AP-HP), the French Ministry of Health (PHRC 1997 AOM 6597–030) and the Etablissement Français des Greffes. In memoriam of Dr Homa KESHTMAND (Department of Internal Medicine, Hôpital Saint-Louis), for a sustained and dedicated work over 15 years at St Louis Hospital, who contributed to patients follow-up and blood samples collection.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Michel, L., Farge, D., Baraut, J. et al. Evolution of serum cytokine profile after hematopoietic stem cell transplantation in systemic sclerosis patients. Bone Marrow Transplant 51, 1146–1149 (2016). https://doi.org/10.1038/bmt.2016.77
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2016.77
This article is cited by
-
Umbilical cord mesenchymal stem cells transplantation in patients with systemic sclerosis: a 5-year follow-up study
Clinical Rheumatology (2024)
-
Autologous hematopoietic stem cell transplantation promotes connective tissue remodeling in systemic sclerosis patients
Arthritis Research & Therapy (2022)
-
Involvement of the myeloid cell compartment in fibrogenesis and systemic sclerosis
Nature Reviews Rheumatology (2019)
-
Hematopoietic Stem Cell Transplantation for Systemic Sclerosis: Review of Current Status
BioDrugs (2019)
-
Long-term immune reconstitution and T cell repertoire analysis after autologous hematopoietic stem cell transplantation in systemic sclerosis patients
Journal of Hematology & Oncology (2017)